Bad news for the cheaters is that this new form of EPO lasts longer in the bloodstream so it's easier for testers to find it. Good news for the chemotherapy and severe anemia patients though.
Alan >From: "Mcewen, Brian T" <[EMAIL PROTECTED]> >Reply-To: "Mcewen, Brian T" <[EMAIL PROTECTED]> >To: track list <[EMAIL PROTECTED]> >Subject: RE: t-and-f: Olympic DQ's >Date: Tue, 5 Mar 2002 10:49:57 -0500 >MIME-Version: 1.0 >Received: from [128.223.142.13] by hotmail.com (3.2) with ESMTP id >MHotMailBE4E3A8400A9400438CE80DF8E0D9AA20; Tue, 05 Mar 2002 08:17:30 -0800 >Received: from darkwing.uoregon.edu (majordom@localhost [127.0.0.1])by >darkwing.uoregon.edu (8.12.2/8.12.2) with ESMTP id g25FoCP6006557for ><[EMAIL PROTECTED]>; Tue, 5 Mar 2002 07:50:12 -0800 >(PST) >Received: (from majordom@localhost)by darkwing.uoregon.edu >(8.12.2/8.12.2/Submit) id g25FoCYS006553for t-and-f-outgoing; Tue, 5 Mar >2002 07:50:12 -0800 (PST) >Received: from ahmler1.mail.eds.com (ahmler1.mail.eds.com >[192.85.154.71])by darkwing.uoregon.edu (8.12.2/8.12.2) with ESMTP id >g25FoAP6006520for <[EMAIL PROTECTED]>; Tue, 5 Mar 2002 07:50:11 >-0800 (PST) >Received: from ahmlir4.mail.eds.com (ahmlir4-2.mail.eds.com >[192.85.154.24])by ahmler1.mail.eds.com (8.11.6/8.11.3) with ESMTP id >g25FoAo18925for <[EMAIL PROTECTED]>; Tue, 5 Mar 2002 10:50:10 >-0500 >Received: from ahmlir4.mail.eds.com (localhost [127.0.0.1])by >ahmlir4.mail.eds.com (8.11.6/8.11.3) with ESMTP id g25Fo8310141for ><[EMAIL PROTECTED]>; Tue, 5 Mar 2002 10:50:08 -0500 (EST) >Received: from usahm102.exmi01.exch.eds.com (usahm102.exmi01.exch.eds.com >[207.37.138.190])by ahmlir4.mail.eds.com (8.11.6/8.11.3) with ESMTP id >g25Fo8o10117for <[EMAIL PROTECTED]>; Tue, 5 Mar 2002 10:50:08 >-0500 (EST) >Received: by usahm102.exmi01.exch.eds.com with Internet Mail Service >(5.5.2655.51)id <14SKJ9H2>; Tue, 5 Mar 2002 10:50:10 -0500 >From [EMAIL PROTECTED] Tue, 05 Mar 2002 08:20:06 -0800 >Message-ID: ><[EMAIL PROTECTED]> >X-Mailer: Internet Mail Service (5.5.2655.51) >Sender: [EMAIL PROTECTED] >Precedence: bulk > >Darbepoietin is very similar to Amgen's product for chemotherapy patients, >Procrit. > >It is supposedly made to address anemia in Kidney dialysis patients rather >than cancer patients. How anemia, and stimulating the production of RBC's, >in each case differs is beyond me right now. > >Along the same lines, I recently saw a "corporate summary" for Amgen in our >local newspaper. It stated in no uncertain terms that Amgen had fully >developed EPO "by 1983". It made no mention of when it was available as a >prescription drug (I was under the impression that it was 1989). > >This is much earlier than I have ever seen in anything I have read. > >/Brian McEwen > >-----Original Message----- >From: Philip Weishaar [mailto:[EMAIL PROTECTED]] >Sent: Tuesday, February 26, 2002 10:42 AM >To: track list >Subject: t-and-f: Olympic DQ's > > >In some ways I hate to bring this up but I am surprised noone has mentioned >the 3 DQ's Sunday in Salt Lake for the using the newest version of EPO >called darpopeitin (sorry about the spelling). Chemical just released and >isn't even on the list of banned substances yet but certainly will be. >What >was interesting was that athletes who were DQ'ed were only DQ'ed for >Saturday and Sunday's events. Earlier tests were negative so those events >stood. > The testers must be catching up with the users at least for a little >while. > >phil weishaar _________________________________________________________________ Chat with friends online, try MSN Messenger: http://messenger.msn.com
